EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC 4.0

The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland

Judith Everts-Graber, Mathias Wenger, Sven Oser, Ueli Studer, Christian Steiner, Hans-Rudolf Ziswiler, Karoline Sromek, Gernot Schmid, Brigitta Gahl, HansJörg Häuselmann, Stephan Reichenbach, Thomas Lehmann

Osteoporosis International · 2024

DOI: 10.1007/s00198-024-07155-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Osteoporosis International, 2024. Verfasst von Judith Everts-Graber und 11 weiteren Autor:innen. Beteiligte Einrichtung: OsteoRheuma Bern, Bahnhofplatz 1, Bern, Switzerland. judith.everts@hin.ch. Hauptthemen laut MEDLINE: Bone Density, Bone Density Conservation Agents, Lumbar Vertebrae, Osteoporosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Bern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityBone Density Conservation AgentsLumbar VertebraeOsteoporosisHumansMaleFemaleAgedProspective StudiesSwitzerlandBone RemodelingAntibodies, MonoclonalBiomarkersAbsorptiometry, PhotonProcollagenHip JointPeptide FragmentsCollagen Type IFemur NeckRegistriesPeptides

Stichwörter der Autor:innen

Bone mineral densityFracturesOsteoporosisRomosozumab

Substanzen

Bone Density Conservation AgentsromosozumabAntibodies, MonoclonalBiomarkersProcollagenprocollagen Type I N-terminal peptidePeptide Fragmentscollagen type I trimeric cross-linked peptideCollagen Type IPeptides

Autor:innen und Institutionen

  • OsteoRheuma Bern, Bahnhofplatz 1, Bern, Switzerland. judith.everts@hin.ch.
  • Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. judith.everts@hin.ch.
  • Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland. judith.everts@hin.ch.
  • Zentrum Für Rheuma- und Knochenerkrankungen, Klinik Im Park, Hirslanden Zürich, Switzerland.
  • OsteoRheuma Bern, Bahnhofplatz 1, Bern, Switzerland.
  • Department of Rheumatology, Lucerne Regional Hospital, Lucerne, Switzerland.

Förderung

  • University of Bern

Zitieren

APA

Everts-Graber, J., Wenger, M., Oser, S., Studer, U., Steiner, C., Ziswiler, H. R., Sromek, K., Schmid, G., Gahl, B., Häuselmann, H., Reichenbach, S., & Lehmann, T. (2024). The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland. Osteoporosis International. https://doi.org/10.1007/s00198-024-07155-9

Vancouver

Everts-Graber J, Wenger M, Oser S, Studer U, Steiner C, Ziswiler HR, et al. The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland. Osteoporosis International. 2024. doi:10.1007/s00198-024-07155-9

BibTeX
@article{EvertsGraber2024,
  author = {Everts-Graber, Judith and Wenger, Mathias and Oser, Sven and Studer, Ueli and Steiner, Christian and Ziswiler, Hans-Rudolf and Sromek, Karoline and Schmid, Gernot and Gahl, Brigitta and Häuselmann, HansJörg and Reichenbach, Stephan and Lehmann, Thomas},
  title = {The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland},
  journal = {Osteoporosis International},
  year = {2024},
  doi = {10.1007/s00198-024-07155-9}
}
Kostenlos starten →